19 November 2014 : Original article
Serum Adiponectin Relates to Shortened Overall Survival in Men with Squamous Cell Esophageal Cancer Treated with Preoperative Concurrent Chemoradiotherapy: A Pilot Study
Milada ZemanováADE, Barbora StaňkováBD, Zuzana UšiakovaBF, Eva TvrzickáAD, Alexandr PazdroBG, Luboš PetruželkaDG, Miroslav ZemanCEFDOI: 10.12659/MSM.891088
Med Sci Monit 2014; 20:2351-2357
Abstract
BACKGROUND: The convergence of nutritional, genetic, and inflammatory factors plays a significant role in the pathophysiology of squamous cell esophageal cancer (SCEC). The parameters of inflammation, indices of nutritional status, and adipocyte-derived hormones such as leptin, adiponectin, and resistin have been shown to be prognostic factors in some gastrointestinal and pancreatic cancers.
MATERIAL AND METHODS: Forty-two patients with SCEC were subjected to a multimodal regimen of concurrent neoadjuvant chemoradiotherapy (CRT) followed by surgery. We retrospectively analyzed the impact of pretreatment values of serum leptin, adiponectin, resistin, soluble leptin receptor, C-reactive protein, TNF alpha, leukocytes, and indices of nutritional status (BMI, plasma total protein, albumin, cholesterol, and triacylglycerols) on overall survival (OS).
RESULTS: Univariate analysis revealed significant a negative correlation between OS and serum adiponectin (p=0.027), and a positive relationship was found between serum albumin (p=0.002), cholesterol (p=0.049) level, and OS. In multivariate analysis, only the trend (p=0.086) for negative serum adiponectin association with the OS was observed.
CONCLUSIONS: In men with SCEC treated by neoadjuvant concurrent CRT and esophagectomy, high pretreatment level of serum adiponectin was associated with shorter OS while the serum albumin and cholesterol were associated with longer OS.
Keywords: Adiponectin - blood, Carcinoma, Squamous Cell - therapy, chemoradiotherapy, Esophageal Neoplasms - therapy, Multivariate Analysis, Pilot Projects, Preoperative Care, Proportional Hazards Models
Editorial
01 January 2025 : Editorial
Editorial: The Human Cell Atlas. What Is It and Where Could It Take Us?DOI: 10.12659/MSM.947707
Med Sci Monit 2025; 31:e947707
In Press
Clinical Research
Quantifying Gait Asymmetry in Stroke Patients: A Statistical Parametric Mapping (SPM) ApproachMed Sci Monit In Press; DOI: 10.12659/MSM.946754
Laboratory Research
Effect of Irrigation Solution Temperature on Bioceramic Sealer Bond StrengthMed Sci Monit In Press; DOI: 10.12659/MSM.946772
Clinical Research
Impact of Smovey Vibration Versus Dumbbell Resistance on Muscle Activation in WomenMed Sci Monit In Press; DOI: 10.12659/MSM.946567
Clinical Research
Five-Year Impact of Weight Loss on Knee Pain and Quality of Life in Obese PatientsMed Sci Monit In Press; DOI: 10.12659/MSM.946550
Most Viewed Current Articles
17 Jan 2024 : Review article 6,962,831
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 699,975
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 23,256
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 17,976
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912